Letters to the Editor
Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1)
M. Garrido-Cumbrera1, H. Marzo-Ortega2, L. Christen3, J. Correa-Fernández4, S. Sanz-Gómez5, V. Navarro-Compán6
- Health & Territory Research (HTR), Universidad de Sevilla, and Spanish Federation of Spondyloarthritis Associations (CEADE), Madrid, Spain. mcumbrera@us.es
- NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospital Trusts, Leeds, and Leeds Institute for Rheumatic and Musculoskeletal Medicine, University of Leeds, UK.
- Patient Engagement, Novartis Pharma AG, Basel, Switzerland.
- Health & Territory Research (HTR), Universidad de Sevilla, Spain.
- Health & Territory Research (HTR), Universidad de Sevilla, Spain.
- IdiPaz, Hospital Universitario La Paz, Madrid, Spain.
on behalf of the REUMAVID Working Group.
CER15129
2022 Vol.40, N°5
PI 1062, PF 1063
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 35084328 [PubMed]
Received: 02/09/2021
Accepted : 18/11/2021
In Press: 27/01/2022
Published: 13/05/2022
